After treatment with BIX-01294 at the indicated concentration for 48 h, both protein and mRNA levels of LC3B increased in DLBCL cells (Fig. 5A and 5B). The gene discussed is MAP1LC3B; the disease is diffuse large B-cell lymphoma.